[Fibrates: mechanism of action, effect on levels of lipids  and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].
Dobordzhginidze
L M
LM
Gratsianskiĭ
N A
NA
D001629:Bezafibrate / Q000494:pharmacology*; D002994:Clofibrate / Q000494:pharmacology*; D005260:Female; D015248:Gemfibrozil / Q000494:pharmacology*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D016032:Randomized Controlled Trials as Topic
D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002994:Clofibrate; D015248:Gemfibrozil; D001629:Bezafibrate